jobs.jnj.com/en/jobs/
Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Switzerland
Our Company

Janssen Healthy Minds Program Explores Major Depressive Disorder

BrainHealthPost alt
Today's Top Reads Close

As there is significant public discussion right now about depression, Janssen Research & Development, LLC, a Johnson & Johnson Company, is posting its Healthy Minds segment about major depressive disorder ahead of its planned release in October to help provide some additional resources on this disorder. Major depression, a largely misunderstood disease, is expected to be the number one cause of disability worldwide by 2030, and tragically there are more than 38,000 suicides in the United States each year.

Featured in the video series is Dr. Husseini Manji, a psychiatrist and neuroscientist, and Global Therapeutic Area Head for Neuroscience at Janssen R&D. The Healthy Minds video series is hosted by Emmy Award-winning broadcast journalist Vicki Mabrey.

Across the globe, approximately 450 million people suffer from a mental or neurological disorder, yet nearly 60 percent who have a known disorder never consult a doctor to better understand their mental health. Lack of awareness and stigma are frequently noted as the reasons those suffering do not seek help. The video series aims to assist in familiarizing these disorders with viewers and reducing the stigma associated with them.

The first video, A Discussion about Brain Health, is available on the Johnson & Johnson YouTube channel and the J&J Corporate Blog. Subsequent videos in the series will be released on a monthly basis throughout the remainder of 2014:

  • Bipolar Disorder – September
  • Alzheimer’s Disease – November
  • Schizophrenia – December

Janssen’s mental health video series is part of the company’s Healthy Minds initiative, dedicated to advancing neuroscience research, news and information regarding mental health. The video project serves as a platform to continue Janssen’s leadership and innovation in neuroscience, mental health education, public health and advocacy.

Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue